GlassScriptPhysician profile
Fernando A Bolufer
NPI 1598784779
$4,572.32
in general payments reported to CMS, 2019-2025
20 companies · $540 in 2025
The $540 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $235 · 2021: $852 · 2022: $900 · 2023: $778 · 2024: $1,036 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,354.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,535.77 | 2022-2025 | |
| Novo Nordisk INC | $949.64 | 2020-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $487.76 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $441.63 | 2019-2025 | Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.89 | 2019-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $157.48 | 2019-2025 | Xifaxan, Trulance |
| Pfizer INC. | $138.89 | 2019-2024 | |
| Abbvie INC. | $135.09 | 2021 | |
| Amgen INC. | $107.22 | 2019-2025 | Otezla, Repatha, Repatha |
| Exact Sciences Corporation | $104.44 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $79.00 | 2019-2021 | |
| Allergan, INC. | $53.23 | 2020 | |
| Phadia US INC. | $40.85 | 2022-2024 | Immunocap |
| Alnylam Pharmaceuticals INC. | $27.54 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.54 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $22.48 | 2024 | Inspire |
| Amarin Pharma, INC. | $19.09 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.78 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Bolufer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.